RAPS Switzerland : Combination Products
Share this training
A Regulatory Roadmap for Combination Products
Combination products (drug/device & device/drug) have become increasingly important in the medical industry. But they do not come without their fair share of challenging regulatory and quality procedures, as well as challenges regarding their development and manufacturing process.
To further understand the challenges caused by the regulatory and quality procedures, RAPS Switzerland are organising an educational event that will give you the “Regulatory Roadmap to Combination Products”.
What to expect?
Speakers from both the Pharmaceutical and Medical Device fields will provide further details and support on Article 117 MDR. The workshop will include case studies and input from agency expert speakers.
Places are limited so make sure you save the date and register your interest by emailing: email@example.com
The event will take place on 17 October 2019 in Bern from 1PM to 5:30PM.